Vivos Therapeutics (VVOS) Depreciation and Depletion (2020 - 2026)
Vivos Therapeutics' (VVOS) quarterly Depreciation and Depletion came in at $300000.0 in Q1 2026, up 50.0% year-on-year from $200000.0 in Q1 2025, and up 250.0% on a QoQ basis from -$200000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Depreciation and Depletion (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Depreciation and Depletion data on file, last reported at $300000.0 in Q1 2026.
- On a quarterly basis, Depreciation and Depletion rose 50.0% year-over-year to $300000.0 in Q1 2026; TTM through Mar 2026 was $800000.0, a 60.0% increase from a year earlier, with the FY2025 full-year figure at $700000.0, up 40.0% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $300000.0, up from -$200000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for VVOS reached as high as $400000.0 in Q3 2025 and fell as low as -$200000.0 in Q4 2025.
- Historically, Depreciation and Depletion has averaged $170588.2 across 5 years, with a median of $200000.0 in 2022.
- On a YoY basis, Depreciation and Depletion climbed as much as 300.0% in 2025 and fell as far as 300.0% in 2025.
- Year by year, Depreciation and Depletion stood at $300000.0 in 2022, then plunged by 33.33% to $200000.0 in 2023, then slumped by 50.0% to $100000.0 in 2024, then slumped by 300.0% to -$200000.0 in 2025, then soared by 250.0% to $300000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $300000.0 in Q1 2026, -$200000.0 in Q4 2025, and $400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Vivos Therapeutics | 5.92 Mn | 3.81 Mn | 3.06 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | -200,000.00 |
| Dec 31, 2025 | -200,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |